Zacks.com featured expert Kevin Matras highlights: Amazon.com Inc., Cogent Communications Group Inc., Concur Technologies, Inc., ViaSat Inc. and Range Resources Corp.
CHICAGO, Oct. 25, 2012 /PRNewswire/ -- Stocks in this week's article include: Amazon.com Inc. (NASDAQ: AMZN), Cogent Communications Group Inc. (NASDAQ: CCOI), Concur Technologies, Inc. (NASDAQ: CNQR), ViaSat Inc. (NASDAQ: VSAT) and Range Resources Corp. (NYSE: RRC). Kevin Matras pulls out his Toxic Stocks bearish screen that gained over 120% in the bear market of 2008, and shows how to use it this year.
Screen of the Week written by Kevin Matras of Zacks Investment Research:
It's been a while since I highlighted a bearish stock picking screen. Typically, I'll only follow a bearish strategy once the market officially enters into bear territory, which is defined as the market being -20%.
However, there's nothing wrong with using a bearish strategy to put toxic stocks on your radar screen to alert you to get out (if you happen to own one of them) or to consider shorting if you don't.
The main theme of this screen is to find overvalued companies.
Usually the best opportunities for short-selling are the ones that are overvalued on valuations, underperforming on growth and are receiving downward earnings estimate revisions.
So how did it do?
In 2008, this strategy, using a 4-week rebalancing period, produced an average compounded return of over 120% while the market plummeted nearly -40%.
In fact, even if you didn't start trading this strategy until the official beginning of the bear market, which began in July of 2008, the strategy still produced an average annual return of over 70%.
And it's not too late to consider this one now.
For the rest of this Screen of the Week article please visit Zacks.com at: http://www.zacks.com/commentary/24230/
Sign up now for your free trial today and start picking better stocks immediately. And with the backtesting feature, you can test your ideas to see how you can improve your trading in both up markets and down markets. Don't wait for the market to get better before you decide to do better. Start learning how to be a better trader today: http://at.zacks.com/?id=111
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy. Learn more about it here http://at.zacks.com/?id=112
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks . As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros http://at.zacks.com/?id=113
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
SOURCE Zacks Investment Research, Inc.
More by this Source
The Zacks Analyst Blog Highlights: Zumiez, Mylan, AbbVie, Santarus and Jazz Pharmaceuticals
May 23, 2013, 09:30 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.